1403 related articles for article (PubMed ID: 22022567)
1. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
2. CGG-repeat dynamics and
Zhou Y; Kumari D; Sciascia N; Usdin K
Mol Autism; 2016; 7():42. PubMed ID: 27713816
[TBL] [Abstract][Full Text] [Related]
3. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations.
Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD
Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045
[TBL] [Abstract][Full Text] [Related]
4. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
[TBL] [Abstract][Full Text] [Related]
5. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene.
Liu XS; Wu H; Krzisch M; Wu X; Graef J; Muffat J; Hnisz D; Li CH; Yuan B; Xu C; Li Y; Vershkov D; Cacace A; Young RA; Jaenisch R
Cell; 2018 Feb; 172(5):979-992.e6. PubMed ID: 29456084
[TBL] [Abstract][Full Text] [Related]
6. Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons.
Graef JD; Wu H; Ng C; Sun C; Villegas V; Qadir D; Jesseman K; Warren ST; Jaenisch R; Cacace A; Wallace O
Eur J Neurosci; 2020 May; 51(10):2143-2157. PubMed ID: 31880363
[TBL] [Abstract][Full Text] [Related]
7. iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.
Doers ME; Musser MT; Nichol R; Berndt ER; Baker M; Gomez TM; Zhang SC; Abbeduto L; Bhattacharyya A
Stem Cells Dev; 2014 Aug; 23(15):1777-87. PubMed ID: 24654675
[TBL] [Abstract][Full Text] [Related]
8. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
[TBL] [Abstract][Full Text] [Related]
10. FMR1 Protein Expression Correlates with Intelligence Quotient in Both Peripheral Blood Mononuclear Cells and Fibroblasts from Individuals with an FMR1 Mutation.
Jiraanont P; Zafarullah M; Sulaiman N; Espinal GM; Randol JL; Durbin-Johnson B; Schneider A; Hagerman RJ; Hagerman PJ; Tassone F
J Mol Diagn; 2024 Jun; 26(6):498-509. PubMed ID: 38522837
[TBL] [Abstract][Full Text] [Related]
11. Human pluripotent stem cell models of Fragile X syndrome.
Bhattacharyya A; Zhao X
Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241
[TBL] [Abstract][Full Text] [Related]
12. Use of human-derived stem cells to create a novel, in vitro model designed to explore FMR1 CGG repeat instability amongst female premutation carriers.
Gustin SLF; Wang G; Baker VM; Latham G; Sebastiano V
J Assist Reprod Genet; 2018 Aug; 35(8):1443-1455. PubMed ID: 29926373
[TBL] [Abstract][Full Text] [Related]
13. microRNAs and Fragile X Syndrome.
Lin SL
Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
[TBL] [Abstract][Full Text] [Related]
14. CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.
Ludwig AL; Espinal GM; Pretto DI; Jamal AL; Arque G; Tassone F; Berman RF; Hagerman PJ
Hum Mol Genet; 2014 Jun; 23(12):3228-38. PubMed ID: 24463622
[TBL] [Abstract][Full Text] [Related]
15. Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation.
Lu P; Chen X; Feng Y; Zeng Q; Jiang C; Zhu X; Fan G; Xue Z
Sci China Life Sci; 2016 Nov; 59(11):1093-1105. PubMed ID: 27730449
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic variability to medication management: an update on fragile X syndrome.
Elhawary NA; AlJahdali IA; Abumansour IS; Azher ZA; Falemban AH; Madani WM; Alosaimi W; Alghamdi G; Sindi IA
Hum Genomics; 2023 Jul; 17(1):60. PubMed ID: 37420260
[TBL] [Abstract][Full Text] [Related]
17. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
Sølvsten C; Nielsen AL
Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
[TBL] [Abstract][Full Text] [Related]
18. Fragile X syndrome full mutation in cognitively normal male identified as part of an Australian reproductive carrier screening program.
Jarmolowicz AI; Baker EK; Bartlett E; Francis D; Ling L; Gamage D; Delatycki MB; Godler DE
Am J Med Genet A; 2021 May; 185(5):1498-1503. PubMed ID: 33544979
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
20. Variation of FMRP Expression in Peripheral Blood Mononuclear Cells from Individuals with Fragile X Syndrome.
Randol JL; Kim K; Ponzini MD; Tassone F; Falcon AK; Hagerman RJ; Hagerman PJ
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
